Health insurance will reimburse monkeypox virus tests 100%, according to an order in the Official Journal on Saturday, following a recommendation to that effect from the Higher Health Authority.
“The development of an epidemic of monkeypox suggests the possibility of confirming cases of infection in the absence of a sufficiently clear clinical picture,” and nucleic acid amplification tests (NAAT) (a technique that includes PCR tests) “make it possible to confirm infections,” emphasizes this decree. “Therefore, it makes sense that these screening tests are covered by health insurance,” the text continues.
On Monday, the Higher Directorate of Health decided to reimburse health insurance for the costs of tests after the Ministry of Health looked into the matter.
The Supreme Health Authority recalled that the diagnosis is based primarily on the examination and questioning of the patient, pointing out that “detection by NAAT test should only be carried out in case of remaining doubts after clinical examination” for “confirmation or not” an infectious disease.
“Thus, the use of this type of test is limited to +suspicious cases+ and +possible cases+, as defined by the French Ministry of Health, and is not necessary in the absence of symptoms,” the health authority clarified.